Mercury Laboratories Ltd — Important, 11-11-2025: Company Update

The company provided an update on its new Small Volume Parenteral (SVPs) plant at Jarod, initially estimated to cost INR 30 Crores with an annual manufacturing capacity of 75 Million units. The commissioning of this injectable plant, previously expected by November 2025, is now deferred by 13 months, with completion anticipated by December 2026. This delay stems from updated compliance and infrastructural requirements for pharmaceutical manufacturing facilities. The company stated there is no material adverse impact on its overall business operations due to this postponement and is working to expedite the project.